The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
复制标题
DOI:
10.1182/blood-2006-07-038059
复制
发表时间:
2007-04-15
期刊:
影响因子:
20.3
通讯作者:
Suzuki, Akira
中科院分区:
文献类型:
--
作者:
Kishimoto, Hiroyuki;Ohteki, Toshiaki;Suzuki, Akira
The tumor suppressor PTEN is mutated in many human cancers. We previously used the Cre-loxP system to generate mice (LckCrePten mice) with a Pten mutation in T-lineage cells. Here we describe the phenotype of Pten-deficient V alpha 14iNKT cells. A failure in the development of V alpha 14iNKT cells occurs in the LckCrePten thymus between stage 2 (CD44(high)NK1.1(-)) and stage 3 (CD44(high)NK1.1(+)), resulting in decreased numbers of peripheral V alpha 14iNKT cells. In vitro, Pten-deficient V alpha 14iNKT cells show reduced proliferation and cytokine secretion in response to alpha GalCer stimulation but enhanced inhibitory Ly49 receptor expression. Following interaction with dendritic cells (DCs) loaded with alpha GalCer, Pten-deficient V alpha 14iNKT cells demonstrate activation of PI3K. Indeed, the effects of the Pten mutation require intact function of the PI3K subunits p110 gamma and p110 delta. In vivo, LckCrePten mice display reduced serum IFN gamma after alpha GalCer administration. Importantly, V alpha 14iNKT cell-mediated protection against the metastasis of melanoma cells to the lung was impaired in the absence of Pten. Thus, the Pten/PI3K pathway is indispensable for the homeostasis and antitumor surveillance function of V alpha 14iNKT cells.